Active tuberculosis | |||
---|---|---|---|
No | Yes | ||
N | 2,468,487 | 21,231 | |
Age (years) | 57 (48–66) | 64 (54–72) | < 0.001 |
< 40 years | 196,728 (8.0) | 782 (3.7) | |
40–64 years | 1,555,698 (63.0) | 10,313 (48.6) | |
≥ 65 years | 716,061 (29.0) | 10,136 (47.7) | |
Sex (male) | 1,481,340 (60.0) | 14,108 (66.5) | < 0.001 |
Body mass index (kg/m2) | 24.9 (22.9–27.1) | 23.6 (21.6–27.1) | < 0.001 |
Smoking | < 0.001 | ||
Non-smoker | 1,368,075 (55.4) | 11,044 (52.0) | |
Ex-smoker | 451,376 (18.3) | 3767 (17.7) | |
Current smoker | 649,036 (26.3) | 6420 (30.2) | |
Alcohol drinking | 251,173 (10.2) | 2589 (12.2) | < 0.001 |
Regular exercise | 505,358 (20.5) | 4062 (19.1) | < 0.001 |
Income (lower 25%) | 518,074 (21.0) | 4825 (22.7) | < 0.001 |
Dyslipidemia | 1,039,708 (42.1) | 8121 (38.3) | < 0.001 |
Hypertension | 1,393,988 (56.5) | 12,777 (60.2) | < 0.001 |
Chronic Kidney disease | 277,637 (11.3) | 3527 (16.6) | < 0.001 |
Cardiovascular disease | 324,264 (13.1) | 3698 (17.4) | < 0.001 |
Duration of diabetes ≥ 5 years | 739,450 (30.0) | 8623 (40.6) | < 0.001 |
Pharmacologic therapy for DM | |||
Insulin | 180,411 (2.1) | 1274 (11.3) | < 0.001 |
Number of OHAs ≥ 3 | 348,593 (14.1) | 4205 (19.8) | < 0.001 |
Medication | |||
Metformin | 1,162,405 (47.1) | 11,229 (52.9) | < 0.001 |
Sulfonylurea | 1,001,747 (40.6) | 10,966 (51.7) | < 0.001 |
DPPIV-inhibitors | 214,362 (8.7) | 1866 (8.8) | 0.5882 |
Thiazolidinedione | 155,753 (6.31) | 1644 (7.7) | < 0.001 |
Alpha-glucosidase inhibitors | 269,829 (10.9) | 3586 (16.9) | < 0.001 |
Systolic BP (mmHg) | 129.2 ± 15.9 | 129.5 ± 16.5 | < 0.001 |
Diastolic BP (mmHg) | 79.2 ± 10.3 | 78.5 ± 10.4 | < 0.001 |
Fasting glucose (mg/dL) | 145.2 ± 47.0 | 150.9 ± 57.9 | < 0.001 |
eGFR (ml/min/1.73 m2) | 85.1 ± 36.4 | 82.4 ± 38.8 | < 0.001 |
Baseline TC (mg/dL) | 197.8 ± 46.9 | 192.0 ± 48.1 | < 0.001 |